HERON ELAINE J

SEC Form 4 insider trading activity

HERON ELAINE J has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VXRT, PVLA, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 18, 2026.

On the most recent filing, HERON ELAINE J is listed as Director at PALVELLA THERAPEUTICS, INC. Inside the rolling window, HERON ELAINE J reported 2 open-market purchases totaling $316K in PVLA and VXRT and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,400 PVLA shares on Feb 27, 2026, worth $300K.

Companies traded

Other insiders at VXRT

Insider Buying

$316K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
PVLAPurchase$300KMar 2SEC ↗
VXRTPurchase$16KNov 21SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has HERON ELAINE J made?

HERON ELAINE J has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VXRT, PVLA since 2025.

Which companies does HERON ELAINE J trade?

HERON ELAINE J has filed SEC Form 4 disclosures for 2 companies, including VXRT, PVLA.

When was HERON ELAINE J's most recent SEC Form 4 filing?

HERON ELAINE J's most recent SEC Form 4 filing on Tracefour is dated Jul 18, 2026.

What is HERON ELAINE J's total buy and sell value in the current window?

Inside the rolling retention window, HERON ELAINE J bought $316K and sold $0 based on SEC Form 4 filings.

What was HERON ELAINE J's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,400 PVLA shares on 2026-02-27, worth $300K, per SEC Form 4 filings.